Signup/Login
If you want to receive notifications of upcoming IPOs, you need to simply sign up or sign in with social networks.
Signup/Login
Can you determine which companies are good and which ones - the trash?
Free Pro-version
IPO Filter
Monitor
IPO today
Upcoming IPO
1847 Goedeker (GOED)
PaxMedica (PXMD)
Vistas Media Acquisition (VMACU)
Yucaipa Acquisition (YAC.U)
Rackspace Technology, Inc. (RXT)
GO Acquisition (GOAC.U)
BigCommerce Holdings, Inc (BIGC)
Rocket Companies, Inc. (RKT)
Oak Street Health, Inc. (OSH)
Acutus Medical Inc (AFIB)
IBEX Holdings Limited (IBEX)
Checkmate Pharmaceuticals, Inc. (CMPI)
Freeline Therapeutics Holdings plc (FRLN)
Priced IPO
Fathom Holdings (FTHM)
Vital Farms, Inc. (VITL)
Vasta Platform Limited (VSTA)
AlloVir, Inc. (ALVR)
Li Auto Inc. (LI)
Vertex, Inc. (VERX)
iTeos Therapeutics, Inc. (ITOS)
Inozyme Pharma, Inc. (INZY)
Annexon, Inc. (ANNX)
Nurix Therapeutics, Inc. (NRIX)
Montrose Environmental Group, Inc. (MEG)
Skillful Craftsman Education Technology Ltd. (EDTK)
Jamf Holding Corp. (JAMF)
Renalytix AI plc (RNLX)
Berkeley Lights, Inc. (BLI)
Pandion Therapeutics, Inc. (PAND)
ALX Oncology Holdings Inc. (ALXO)
Trean Insurance Group, Inc. (TIG)
Relay Therapeutics, Inc. (RLAY)
GoHealth, Inc. (GOCO)
More companies

PPD, Inc. (PPD)

Sector - Healthcare

Price chart

Company News

IPO Profile

About company

They are a leading provider of drug development services to the biopharmaceutical industry, focused on helping their customers bring their new medicines to patients around the world. They have been in the drug development services business for more than 30 years, providing a comprehensive suite of clinical development and laboratory services to pharmaceutical, biotechnology, medical device and government organizations, as well as other industry participants. Over that time, they have developed a track record of consistent quality, delivery and continuous innovation that has enabled them to grow faster than their underlying market over the past five years and deliver strong financial results. In 2018, they served all of the top 50 biopharmaceutical companies in the world, as ranked by 2018 research and development spending, and were involved in 66 drug approvals. They also participated in the development of all of 2018's top ten selling drugs, as ranked by 2018 revenue. Since 2014, they have also worked with over 300 companies in the growing biotechnology sector through their PPD Biotech model, which was built specifically to serve the unique needs of this customer segment.
Industry
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
CEO CFO
David Simmons Christopher G. Scully
Employees Founded
23000 1985

Contacts

Address: 929 North Front Street, Wilmington, NC 28401, US

Telephone: (910) 251-0081

Web page: http://www.ppdi.com

IPO information

Expected Date 2/6/2020
Status Priced
Exchange NASDAQ
Lockup Period Expiration .Pro
Quiet Period Expiration .Pro
Old Price Range
-
Share prices ($)

Financial Data (last reporting year)

Market Cap (MM) $9164.5
Revenues (MM) $3962.8
Net Income (Loss) (MM) $84.5

Voting

What do you think will happen with the PPD share price after the next 3-6 months? 🔥 (+ 10% or more, flat (+ -10%), -10% or less)

Number of votes: img
Shares Initial (MM) 60
Shares Revised (MM) 60
Expected offer amount (MM) $1530
Realized offer amount(MM) $1620
Underwriters
Barclays/ JP Morgan/ Morgan Stanley/ Goldman Sachs/ BofA Securities/ Credit Suisse/ Jefferies/ UBS Investment Bank/ Citigroup/ Deutsche Bank/ Evercore ISI/ HSBC/ Mizuho Securities
CO-Managers
Baird/ WIlliam Blair/ Drexel Hamilton

Sector: Healthcare

Tweets about $PPD

Tweets volume:

RT volume:

Timeframe:

Google Trends Stats